Blueprint Medicines Corp
BPMC
Market Cap$8.36B
Close$
$95.39
26.3% downside
Current Fair Value
26.3% downsideOvervalued by 26.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.36 Billion |
|---|---|
| Enterprise Value | $8.36 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.07 |
| Beta | 0.83 |
| Outstanding Shares | 63,600,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -52.87 |
|---|---|
| PEG | 53.17 |
| Price to Sales | 16.18 |
| Price to Book Ratio | 25.89 |
| Enterprise Value to Revenue | 14.88 |
| Enterprise Value to EBIT | -70.73 |
| Enterprise Value to Net Income | -54 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.37 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Blueprint Medicines Corp
CEO: Jeffrey Albers